Dr. Ruth M. O'Regan, MD

  • Rochester, NY
  • Medical oncologist
NPI1215981238PAC ID0648254136
Medicare services, 2024
96
Medicare patients, 2024
23
Part D claims, 2024
66
Publications
107
Clinical trials
8
Practice address
601 Elmwood Ave, Rochester, NY 14642
Practice phone
Call (585) 275-2121
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Strong Memorial Hospital

Hospital · Rochester, New York

See all 5 affiliations

Find Dr. O'Regan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Ruth M. O'Regan is a medical oncologist in Rochester, New York

Dr. O'Regan practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. O'Regan's NPI, 1215981238, was assigned on May 22, 2006. Dr. O'Regan holds New York license 308369.

NPI and contact details
Medicare PAC ID
0648254136
NPI enumeration date
May 22, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(585) 275-2121
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
64
Medical school graduation
1988

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Ruth M. O'Regan practices at Strong Memorial Hospital in Rochester, New York

Dr. O'Regan's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Source: Dmand AI Affiliation Data

Dr. Ruth M. O'Regan is affiliated with 2 sites of care and 3 medical groups

Dr. O'Regan's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dr. O'Regan is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. O'Regan to 2 more medical groups, each named with a free account.

See all 5 affiliations for Dr. O'Regan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Ruth M. O'Regan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Regan practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Strong Memorial HospitalAvailable with a free account
+1 more site and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. O'Regan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Rochester Medical Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Ruth M. O'Regan is one of 458 medical oncologists in New York

Medical oncology is Dr. O'Regan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. O'Regan is licensed in New York.

Specialties and state licenses

  • Medical oncology, New YorkPrimaryLicense 308369 · taxonomy 207RX0202X

Medical oncologists near Dr. O'Regan

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Ruth M. O'Regan billed Medicare for 96 services in 2024

CMS data shows 96 Medicare services from Dr. O'Regan across 2 procedure codes in 2024, for 23 Medicare patients. Medicare paid $4,405 for them. Every service was in an office.

Medicare services, 202496
Medicare patients23
Paid by Medicare$4,405
Procedure codes2

Dr. O'Regan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 572024: 594%
Other services
2023: 02024: 37

Dr. O'Regan compared with the New York median for medical oncologists, 2024

  • Dr. O'Regan
  • New York median
Medicare services
96vs 34072% below
Medicare patients
23vs 11279% below
Part D claims
26vs 13080% below

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. O'Regan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. O'Regan

Need commercial claims for Dr. O'Regan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. O'Regan and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Ruth M. O'Regan treated 23 Medicare patients in 2024, average age 72

CMS counts 23 Medicare patients who saw Dr. O'Regan in 2024. 75% of them have cancer, and 65% have high blood pressure. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. O'Regan's median patient age at 62, with 98% women.

Medicare patients, 202423
Average age72
Average risk score1.43

Chronic conditions among Dr. O'Regan's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure65%
  3. High cholesterol65%

Share of Medicare patients with each condition. A patient can have several.

Dr. O'Regan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 62

Patient panel by sex, all payers

  • Women98%
  • Men1%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Ruth M. O'Regan wrote 66 Medicare Part D claims in 2024

In 2024, Dr. O'Regan wrote 66 Medicare Part D claims for 32 patients. 86% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $527 in total drug cost. In 2023, CMS named 37 claims across 1 drug.

Part D claims, 202466
Drugs named by CMS1
Total drug cost$527
Part D patients32

Dr. O'Regan's Part D claims by kind of drug, 2024

  • Generic57 claims86%
  • Brand-name and other9 claims14%

Dr. O'Regan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 372024: 2630%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. O'Regan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Ruth M. O'Regan takes part in Medicare

Dr. O'Regan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find medical oncologists like Dr. O'Regan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Ruth M. O'Regan has 107 publications on record

Dmand AI links 107 papers to Dr. O'Regan, published from 2010 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Breast Neoplasms, Receptor, ErbB-2 and Receptors, Estrogen. Dr. O'Regan has published most often in Cancer. Dr. O'Regan's most frequent co-authors are Kari Braun Wisinski, MD, Ajay Dhakal, MBBS and William J. Gradishar, MD.

Papers107
Years published2010 to 2025

Dr. O'Regan's papers by year, 2016 to 2025

Topics Dr. O'Regan writes about most

  • Breast Neoplasms
  • Receptor, ErbB-2
  • Receptors, Estrogen
  • Antineoplastic Combined Chemotherapy Protocols
  • Biomarkers, Tumor
  • Antineoplastic Agents
  • Chemotherapy, Adjuvant
  • Receptors, Progesterone

Dr. O'Regan's most frequent co-authors

Recent publications by Dr. O'Regan

See all 107 publications and co-authors

See who Dr. O'Regan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. O'Regan works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Ruth M. O'Regan has worked on 8 clinical trials

Dmand AI links Dr. O'Regan to 8 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. University of Wisconsin, Madison sponsors the most, 3.

Clinical trials with Dr. O'Regan by phase

  1. 1Phase 1: 1 trial
  2. 3Phase 2: 3 trials
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. O'Regan's trials

  • Breast Neoplasms
  • Breast Diseases
  • Triple Negative Breast Neoplasms
  • Brain Neoplasms
  • Central Nervous System Neoplasms

Investigators on the most trials with Dr. O'Regan

Recent clinical trials with Dr. O'Regan

See all 8 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Ruth M. O'Regan received $83,774 in industry payments from 2016 to 2025

CMS Open Payments shows 134 general payments to Dr. O'Regan from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Puma Biotechnology, Inc. paid the most, $18,340. It also lists 5 research payments totaling $13,006 from 2017 to 2024.

General payments to Dr. O'Regan by program year, 2016 to 2025

General payments to Dr. O'Regan by kind, 2016 to 2025

$83.8Kin total
  • Consulting fees$53,15263%
  • Travel and lodging$17,26721%
  • Accredited education speaker fees$4,2505%
  • Speaker and faculty fees$4,1605%
  • Other$4,9336%

Companies that paid Dr. O'Regan the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. O'Regan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Ruth M. O'Regan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Ruth M. O'Regan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Ruth M. O'Regan's NPI number?

Dr. Ruth M. O'Regan's NPI number is 1215981238. It was assigned on May 22, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Ruth M. O'Regan?

Dr. Ruth M. O'Regan is a medical oncologist in Rochester, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Ruth M. O'Regan practice?

Dr. O'Regan practices at 601 Elmwood Ave, Rochester, NY 14642. Dr. O'Regan's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Dmand AI also links Dr. O'Regan to 2 medical groups.

What is Dr. Ruth M. O'Regan's office phone number?

The practice phone on file for Dr. O'Regan is (585) 275-2121.

What is Dr. Ruth M. O'Regan's medical license number?

Dr. O'Regan holds New York license 308369.

Which hospitals is Dr. Ruth M. O'Regan affiliated with?

Dr. O'Regan practices at Strong Memorial Hospital in Rochester, New York. Dr. O'Regan is also affiliated with Highland Hospital.

What medical group is Dr. Ruth M. O'Regan part of?

Dr. O'Regan is linked to University of Rochester Medical Faculty Group (URMFG). Dmand AI links Dr. O'Regan to 2 more medical groups.

Does Dr. Ruth M. O'Regan accept Medicare?

Yes. CMS data shows Dr. O'Regan billed Medicare for 96 services in 2024, and Dr. O'Regan accepts Medicare assignment.

How many Medicare patients does Dr. Ruth M. O'Regan see?

CMS counts 23 Medicare patients who saw Dr. O'Regan in 2024, with an average age of 72.

What services does Dr. Ruth M. O'Regan bill to Medicare?

In 2024, Dr. O'Regan's most billed Medicare services were office visit, established patient (99214) and medicare service (G2211).

Show 5 more questionsShow fewer questions

What drugs does Dr. Ruth M. O'Regan prescribe most?

In 2024 Medicare Part D data, Dr. O'Regan's most prescribed drugs by claims were Anastrozole.

Has Dr. Ruth M. O'Regan received payments from drug or device companies?

CMS Open Payments shows $83,774 in general payments to Dr. O'Regan from 17 companies from 2016 to 2025. The largest total came from Puma Biotechnology, Inc.

How long has Dr. Ruth M. O'Regan been practicing?

Dr. O'Regan graduated from medical school in 1988, 38 years ago.

Does Dr. Ruth M. O'Regan do research?

Dmand AI links 107 publications to Dr. O'Regan, published from 2010 to 2025. Dr. O'Regan has worked on 8 clinical trials.

Who does Dr. Ruth M. O'Regan publish with?

Dr. O'Regan's most frequent co-authors are Kari Braun Wisinski, MD (13 shared papers), Ajay Dhakal, MBBS (9 shared papers) and William J. Gradishar, MD (8 shared papers).

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)